24 Einträge | 1, 2 › » |
Seite 1 / 2
![]() |
Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46. |
Jungwirth U, Gojo J, Tuder T, Walko G, Holcmann M, Schöfl T, Nowikovsky K, Wilfinger N, Schoonhoven S, Kowol CR, Lemmens-Gruber R, Heffeter P, Keppler BK, Berger W |
Molecular cancer therapeutics. 2014 Jul 31. pii: 1535-7163.MCT-14-0087. doi: 10.1158/1535-7163.MCT-14-0087 |
PMID: 25082959 |
Triapine and a more potent dimethyl derivative induce endoplasmic reticulum stress in cancer cells. |
Trondl R, Flocke LS, Kowol CR, Heffeter P, Jungwirth U, Mair GE, Steinborn R, Enyedy ÉA, Jakupec MA, Berger W, Keppler BK |
Molecular pharmacology. 2013 Dec 30. pii: mol.113.090605. doi: 10.1124/mol.113.090605 |
PMID: 24378333 |
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo. |
Heffeter P, Atil B, Kryeziu K, Groza D, Koellensperger G, Körner W, Jungwirth U, Mohr T, Keppler BK, Berger W |
European journal of cancer (Oxford, England : 1990). 2013 Jun 18. pii: S0959-8049(13)00426-7. doi: 10.1016/j.ejca.2013.05.018. pmc: PMC3807657 |
PMID: 23790465 |
Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair. |
Kryeziu K, Jungwirth U, Hoda MA, Ferk F, Knasmüller S, Karnthaler-Benbakka C, Kowol CR, Berger W, Heffeter P |
Molecular cancer therapeutics. 2013 Apr 2. pii: 1535-7163.MCT-13-0065. doi: 10.1158/1535-7163.MCT-13-0065 |
PMID: 23548265 |
Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones. |
Heffeter P, Pirker C, Kowol CR, Herrman G, Dornetshuber R, Miklos W, Jungwirth U, Koellensperger G, Keppler BK, Berger W |
Biochemical pharmacology. 2012 Mar 15. pii: S0006-2952(12)00196-7. doi: 10.1016/j.bcp.2012.03.004. pmc: PMC3342514 |
PMID: 22426010 |
Anticancer activity of methyl-substituted oxaliplatin analogs. |
Jungwirth U, Xanthos DN, Gojo J, Bytzek AK, Körner W, Heffeter P, Abramkin SA, Jakupec MA, Hartinger CG, Windberger U, Galanski M, Keppler BK, Berger W |
Molecular pharmacology. 2012 Feb 13. pii: mol.111.077321. doi: 10.1124/mol.111.077321. pmc: PMC3375001. mid: UKMS48669 |
PMID: 22331606 |
Anticancer activity of metal complexes: involvement of redox processes. |
Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P |
Antioxidants & redox signaling. 2011 May 11. doi: 10.1089/ars.2010.3663. pmc: PMC3371750. mid: UKMS48667 |
PMID: 21275772 |
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339. |
Heffeter P, Böck K, Atil B, Reza Hoda MA, Körner W, Bartel C, Jungwirth U, Keppler BK, Micksche M, Berger W, Koellensperger G |
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry. 2010 Mar 11. doi: 10.1007/s00775-010-0642-1. pmc: PMC3371400. mid: UKMS48674 |
PMID: 20221888 |
Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772). |
Heffeter P, Popovic-Bijelic A, Saiko P, Dornetshuber R, Jungwirth U, Voevodskaya N, Biglino D, Jakupec MA, Elbling L, Micksche M, Szekeres T, Keppler BK, Gräslund A, Berger W |
Current cancer drug targets. 2009 Aug 1. pii: CCDT-ABS-01. pmc: PMC3377860. mid: UKMS48672 |
PMID: 19508176 |
Resistance against novel anticancer metal compounds: differences and similarities. |
Heffeter P, Jungwirth U, Jakupec M, Hartinger C, Galanski M, Elbling L, Micksche M, Keppler B, Berger W |
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 2008 Apr 3. pii: S1368-7646(08)00017-4. doi: 10.1016/j.drup.2008.02.002 |
PMID: 18394950 |
Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models. |
Göschl S, Schreiber-Brynzak E, Pichler V, Cseh K, Heffeter P, Jungwirth U, Jakupec MA, Berger W, Keppler BK |
Metallomics : integrated biometal science. 2017 Feb 16. doi: 10.1039/c6mt00226a |
PMID: 28205649 |
Blood alterations preceding clinical manifestation of glioblastoma. |
Ilhan-Mutlu A, Wagner L, Wöhrer A, Jungwirth S, Marosi C, Fischer P, Preusser M |
Cancer investigation. 2012 Oct 12. doi: 10.3109/07357907.2012.725443 |
PMID: 23061753 |
Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo. |
Erkan EP, Senfter D, Madlener S, Jungwirth G, Ströbel T, Saydam N, Saydam O |
Cancer gene therapy. 2016 Dec 16. pii: cgt201678. doi: 10.1038/cgt.2016.78 |
PMID: 27982017 |
Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications. |
Senfter D, Erkan EP, Özer E, Jungwirth G, Madlener S, Kool M, Ströbel T, Saydam N, Saydam O |
Pediatric blood & cancer. 2017 Jun 9. doi: 10.1002/pbc.26670 |
PMID: 28598542 |
Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers. |
Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J, Mitterhauser M, Wadsak W, Windischberger C, Kasper S, Lanzenberger R |
NeuroImage. 2017 Dec 29. pii: S1053-8119(17)31116-3. doi: 10.1016/j.neuroimage.2017.12.092 |
PMID: 29292133 |
Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. |
Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J |
Journal of Alzheimer's disease : JAD. pii: JAD171036. doi: 10.3233/JAD-171036 |
PMID: 29480199 |
Effects of Medical Device Regulations on the Development of Stand-Alone Medical Software: A Pilot Study. |
Blagec K, Jungwirth D, Haluza D, Samwald M |
Studies in health technology and informatics. |
PMID: 29726435 |
Evidence-Based Practices and Use among Employees and Students at an Austrian Medical University. |
Haluza D, Jungwirth D, Gahbauer S |
Journal of clinical medicine. 2021 Sep 27. pii: jcm10194438. doi: 10.3390/jcm10194438 |
PMID: 34640459 |
Fitness and the Crisis: Impacts of COVID-19 on Active Living and Life Satisfaction in Austria. |
Jungwirth D, Weninger CA, Haluza D |
International journal of environmental research and public health. 2021 Dec 11. pii: ijerph182413073. doi: 10.3390/ijerph182413073 |
PMID: 34948682 |
Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. |
Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Georgious T, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD |
BMJ open. 2022 May 9. pii: bmjopen-2021-057384. doi: 10.1136/bmjopen-2021-057384 |
PMID: 35534067 |
24 Einträge | 1, 2 › » |
Seite 1 / 2
![]() |